New melanoma driver genes found in largest DNA sequencing study to date

July 29, 2012 By Helen Dodson
New melanoma driver genes found in largest DNA sequencing study to date
The Yale study used DNA sequencing to obtain the most comprehensive picture yet of the molecular landscape of melanoma. (Illustration by Michael Helfenbein)

(Medical Xpress) -- Yale Cancer Center geneticists, biochemists, and structural biologists have painted the most comprehensive picture yet of the molecular landscape of melanoma, a highly aggressive and often deadly skin cancer. The study appears in the July 29 advance online publication of Nature Genetics.

Melanoma, precipitated mainly by excessive exposure to the sun’s ultra-violet (UV) radiation, causes the vast majority of all deaths related to skin cancer. There will be around 76,000 new cases of melanoma and 9,000 deaths from the disease in the United States this year.

The Yale study used powerful DNA sequencing technologies to examine 147 melanomas originating from both sun-exposed and sun-shielded sites.

The study revealed an excess of UV-induced mutations in sun-exposed melanomas. Most of these are passenger mutations that do not have a functional role in melanoma. “We devised a mathematical model to sort out the relevant DNA alterations from over 25,000 total mutations,” says lead author Michael Krauthammer, associate professor of pathology, who directed the bioinformatics effort of the study.

The analysis identified a frequent “gain-of-function” mutation in the RAC1 gene that has all the hallmarks of UV-damage. The study provided evidence that the mutant protein induces accelerated growth and movements among normal pigment cells, which are melanoma’s cells of origin. “It likely occurs at an early stage of tumor development and promotes malignant cell growth and spread to distant sites,” said corresponding author Ruth Halaban, senior research scientist at Yale School of Medicine and a member of Yale Cancer Center.

The Yale scientists say the RAC1 oncogenic mutation occurred in about 9% of melanomas from sun-exposed skin, and is the third most frequent mutation after the known BRAF and NRAS. They believe the prevalence of RAC1 mutation warrants development of therapies targeting that particular pathway.

The team also identified mutations that disable proteins — known as tumor suppressors — which suppress malignancy. Notably, the mutated protein known as PPP6C occurred only in tumors already mutated in BRAF and NRAS genes. “Our study mapped out a new, cooperative pathway for cancer development,” Halaban explained.

Finally, the study reveals new insights into the rarer melanomas from parts of the body shielded from the sun. Instead of mutations, these melanomas had duplicate copies of known oncogenes.

Explore further: Panel of melanoma mutations opens door to new treatment possibilities

Related Stories

Panel of melanoma mutations opens door to new treatment possibilities

November 15, 2011
Researchers have developed a new genetic screening tool that will aid in the investigation of possible treatments for patients with melanoma and the unique genetic mutations that may accompany the disease, according to data ...

Second mutation in BRAF-mutated melanoma doesn't contribute to resistance

April 1, 2012
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.

Uncommon BRAF mutation in melanoma sensitive to MEK inhibitor drug therapy

July 16, 2012
An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to MEK inhibitor drugs, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.

Scientists discover melanoma-driving genetic changes caused by sun damage

July 19, 2012
It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer?

Recommended for you

A math concept from the engineering world points to a way of making massive transcriptome studies more efficient

November 17, 2017
To most people, data compression refers to shrinking existing data—say from a song or picture's raw digital recording—by removing some data, but not so much as to render it unrecognizable (think MP3 or JPEG files). Now, ...

Genetic mutation in extended Amish family in Indiana protects against aging and increases longevity (Update)

November 15, 2017
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern ...

Genetic variant prompts cells to store fat, fueling obesity

November 13, 2017
Obesity is often attributed to a simple equation: People are eating too much and exercising too little. But evidence is growing that at least some of the weight gain that plagues modern humans is predetermined. New research ...

Discovering a protein's role in gene expression

November 10, 2017
Northwestern Medicine scientists have discovered that a protein called BRWD2/PHIP binds to histone lysine 4 (H3K4) methylation—a key molecular event that influences gene expression—and demonstrated that it does so via ...

Twin study finds genetics affects where children look, shaping mental development

November 9, 2017
A new study co-led by Indiana University that tracked the eye movement of twins finds that genetics plays a strong role in how people attend to their environment.

Boy with rare disease gets brand new skin with gene therapy

November 8, 2017
Doctors treating a critically ill boy with a devastating skin disease used experimental gene therapy to create an entirely new skin for most of his body in a desperate attempt to save his life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.